Azeloprazole
Small moleculeexperimental
Azeloprazole is a drug under investigation for acid-related medical conditions responsive to suppressing the production of stomach acid. It is considered a member of the proton pump inhibitor class of medications. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2011 (NCT01390714)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
ATP4B inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
Cc1cnc(C[S@@+]([O-])c2nc3ccccc3[nH]2)c(C)c1OCC1COC(C)(C)OC1- Mol. weight
- 429.54 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaAzeloprazole ↗
- ChEMBLCHEMBL4300945 ↗
Also known as
- e3710
- e3710
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01390714 | Phase 1 | Jul 1, 2011 | California Clinical Trials, Eisai |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| California Clinical Trials | For profit | 1 | 0 | 1 | 2011 |
| Eisai | For profit | 1 | 1 | 1 | 2011 |
2 organizations
Page 1 / 1